RBI
ALLO icon

Raiffeisen Bank International’s Allogene Therapeutics ALLO Stock Holding History

Raiffeisen Bank International’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Sell
700,000
-200,000
-22% -$401K 0.02% 343
2025
Q4 		$1.18M Buy
900,000
+450,000
+100% +$594K 0.02% 325
2025
Q3 		$572K Buy
450,000
+48,000
+12% +$57.2K 0.01% 407
2025
Q2 		$498K Hold
402,000
– – 0.01% 375
2025
Q1 		$623K Sell
402,000
-28,000
-7% -$52.8K 0.01% 342
2024
Q4 		$903K Buy
+430,000
New +$1.06M 0.01% 281

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raiffeisen Bank International's ALLO Position: Q1 2026 in Review

Raiffeisen Bank International reduced its Allogene Therapeutics (ALLO) stake by 22% in Q1 2026, selling an estimated $401K and leaving 700,000 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #343.

Raiffeisen Bank International first reported a position in ALLO in Q4 2024 and has held it in 6 quarters since. 208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Raiffeisen Bank International held 700,000 shares of Allogene Therapeutics worth $1.55M as of Q1 2026.
  • Raiffeisen Bank International sold 200,000 Allogene Therapeutics shares in Q1 2026, an estimated $401K.
  • Allogene Therapeutics made up 0.02% of Raiffeisen Bank International's portfolio in Q1 2026, its #343 holding.
  • Raiffeisen Bank International first reported a position in Allogene Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.